Wealthfront Advisers’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,193	Closed	-$413K	–	874
2024 Q1	$413K	Sell	1,193 -130	-10%	-$42.7K	﹤0.01%	757
2023 Q4	$427K	Buy	1,323 +610	+86%	+$191K	﹤0.01%	744
2023 Q3	$256K	Buy	+713	New	+$275K	﹤0.01%	784
2023 Q2	–	Sell	-585	Closed	-$280K	–	825
2023 Q1	$280K	Buy	585 +28	+5%	+$13.1K	﹤0.01%	759
2022 Q4	$234K	Sell	557 -32	-5%	-$12.9K	﹤0.01%	750
2022 Q3	$246K	Sell	589 -388	-40%	-$193K	﹤0.01%	722
2022 Q2	$484K	Sell	977 -424	-30%	-$221K	﹤0.01%	599
2022 Q1	$789K	Buy	1,401 +108	+8%	+$65.1K	﹤0.01%	557
2021 Q4	$977K	Sell	1,293 -15	-1%	-$11.2K	﹤0.01%	496
2021 Q3	$975K	Buy	1,308 +23	+2%	+$17.2K	﹤0.01%	476
2021 Q2	$828K	Sell	1,285 -49	-4%	-$29.8K	﹤0.01%	457
2021 Q1	$762K	Sell	1,334 -149	-10%	-$88.2K	﹤0.01%	411
2020 Q4	$865K	Buy	1,483 +330	+29%	+$188K	0.01%	377
2020 Q3	$594K	Buy	1,153 +646	+127%	+$327K	﹤0.01%	397
2020 Q2	$229K	Buy	+507	New	+$224K	﹤0.01%	482